The PI3K/AKT signaling pathway was studied using Western blot and ELISA, with IGF-1 and the PI3K inhibitor LY294002 used to validate the findings.<h4>Results</h4>DF demonstrated dose-dependent inhibitory effects on MM cell proliferation, migration, and invasion. Here, IGF1 is linked to Miyoshi myopathy.